The article "Fosfomycin Effectively Prevents Drug-Induced Kidney Damage in Cystic Fibrosis Patients" discusses the results of a prospective randomized study demonstrating the significant nephroprotective effect of fosfomycin when used in combination with an aminoglycoside and polymyxin to treat pulmonary infections in cystic fibrosis patients.

Thus, it can be confidently stated that, in addition to its proven antimicrobial action against multidrug-resistant bacteria, which forms the basis for effective therapy of infections in various locations, fosfomycin also prevents serious adverse drug reactions from other antibiotics.